Clear Creek Bio doses first patient in Covid-19 trial with brequinar

This article was originally published here

The company has secured clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application of brequinar to treat Covid-19. Brequinar is an

The post Clear Creek Bio doses first patient in Covid-19 trial with brequinar appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply